82497-132Level 3
Rolvedon (eflapegrastim-xnst)
**Product type:** Human Prescription Drug
**Active ingredient:** EFLAPEGRASTIM
**Strength:** 13.2 mg/.6mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Assertio Specialty Pharmaceuticals, LLC
**Marketing category:** BLA (BLA761148)
**Pharmacologic class:** Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]
GET
/api/v1/systems/ndc_fda/nodes/82497-132Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.